115 related articles for article (PubMed ID: 15849452)
1. Increased reactive oxygen species and anti-oxidative response in mitochondrial cardiomyopathy.
Ishikawa K; Kimura S; Kobayashi A; Sato T; Matsumoto H; Ujiie Y; Nakazato K; Mitsugi M; Maruyama Y
Circ J; 2005 May; 69(5):617-20. PubMed ID: 15849452
[TBL] [Abstract][Full Text] [Related]
2. Rapid progression of cardiomyopathy in mitochondrial diabetes.
Momiyama Y; Atsumi Y; Ohsuzu F; Ui S; Morinaga S; Matsuoka K; Kimura M
Jpn Circ J; 1999 Feb; 63(2):130-2. PubMed ID: 10084376
[TBL] [Abstract][Full Text] [Related]
3. An 80-year-old mitochondrial disease patient with A3243G tRNA(Leu(UUR)) gene presenting cardiac dysfunction as the main symptom.
Higashikata T; Koyama J; Shimada H; Yazaki M; Owa M; Ikeda S
Intern Med; 2001 May; 40(5):405-8. PubMed ID: 11393411
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial cardiomyopathy--case report.
Steiner I; Zeman J; Spacek J; Hansíková H; Wenchich L
Cesk Patol; 2002 Jan; 38(1):41-5. PubMed ID: 11933462
[TBL] [Abstract][Full Text] [Related]
5. [Cardiomyopathy showing progression from diffuse left ventricular hypertrophy to dilated phase associated with mitochondrial DNA point mutation A3243G: A case report].
Ohmoto N; Fujiwara Y; Kibira S; Kobayashi M; Saito T; Miura M
J Cardiol; 2003 Jan; 41(1):21-7. PubMed ID: 12564110
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis of mitochondrial cardiomyopathies: the need for a multidisciplinary approach].
Santorelli FM; Bertini E
G Ital Cardiol; 1999 Oct; 29(10):1181-3. PubMed ID: 10546130
[No Abstract] [Full Text] [Related]
7. Cardiomyopathy in respiratory chain disorders.
Guenthard J; Wyler F; Fowler B; Baumgartner R
Arch Dis Child; 1995 Mar; 72(3):223-6. PubMed ID: 7741568
[TBL] [Abstract][Full Text] [Related]
8. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
[TBL] [Abstract][Full Text] [Related]
9. Ablation of ALCAT1 mitigates hypertrophic cardiomyopathy through effects on oxidative stress and mitophagy.
Liu X; Ye B; Miller S; Yuan H; Zhang H; Tian L; Nie J; Imae R; Arai H; Li Y; Cheng Z; Shi Y
Mol Cell Biol; 2012 Nov; 32(21):4493-504. PubMed ID: 22949503
[TBL] [Abstract][Full Text] [Related]
10. [Mitochondrial myopathy, deafness and type 2 diabetes mellitus with tRNALeu(UUR) point mutation in mitochondrial DNA].
Stratilová L; Zeman J; Hansíková H; Houstĕk J; Hermanská J; Dudková Z; Konrádová V; Hůlková H; Elleder M
Cas Lek Cesk; 1998 Jul; 137(14):430-3. PubMed ID: 9748738
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial cardiomyopathy: molecular and biochemical analysis.
Marin-Garcia J; Goldenthal MJ
Pediatr Cardiol; 1997; 18(4):251-60. PubMed ID: 9175519
[TBL] [Abstract][Full Text] [Related]
12. [Case of diabetes mellitus with mitochondrial cardiomyopathy].
Shin I; Toyooka T; Yan I; Ueshino A; Kobayakawa T; Oniwa N; Aoyagi A; Sugiura K; Momomura S; Komata M
Nihon Naika Gakkai Zasshi; 1999 Jul; 88(7):1324-5. PubMed ID: 10465982
[No Abstract] [Full Text] [Related]
13. [Advanced sequelae of apical hypertrophic cardiomyopathy: report of two cases with wall motion abnormalities].
Kusukawa J; Suwa M; Nakayama Y; Hirota Y; Kawamura K; Adachi I; Akagi H
J Cardiol; 1988 Mar; 18(1):259-69. PubMed ID: 3221316
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin 2 Offers Protection against Mitochondrial Oxidative Stress in H9c2 Cells and against Myocardial Hypertrophy Induced by Hyperglycemia.
Li H; Xu C; Li Q; Gao X; Sugano E; Tomita H; Yang L; Shi S
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914755
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial defects in cardiomyopathy and neuromuscular disease.
Wallace DC
Am Heart J; 2000 Feb; 139(2 Pt 3):S70-85. PubMed ID: 10650320
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic cardiomyopathy due to the mitochondrial DNA mutation m.3303C>T diagnosed in an adult male.
Palecek T; Tesarova M; Kuchynka P; Dytrych V; Elleder M; Hulkova H; Hansikova H; Honzik T; Zeman J; Linhart A
Int Heart J; 2012; 53(6):383-7. PubMed ID: 23258140
[TBL] [Abstract][Full Text] [Related]
17. Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species.
Redout EM; Wagner MJ; Zuidwijk MJ; Boer C; Musters RJ; van Hardeveld C; Paulus WJ; Simonides WS
Cardiovasc Res; 2007 Sep; 75(4):770-81. PubMed ID: 17582388
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin-2 inhibits mitochondrial reactive oxygen species generation and apoptosis stress kinase-1 activity to maintain cardiac function.
Huang Q; Zhou HJ; Zhang H; Huang Y; Hinojosa-Kirschenbaum F; Fan P; Yao L; Belardinelli L; Tellides G; Giordano FJ; Budas GR; Min W
Circulation; 2015 Mar; 131(12):1082-97. PubMed ID: 25628390
[TBL] [Abstract][Full Text] [Related]
19. Severe mitochondrial cardiomyopathy and extra-neuromuscular abnormalities in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episode (MELAS).
Ishikawa Y; Asuwa N; Ishii T; Masuda S; Kiguchi H; Hirai S; Akashi N; Yonenami K; Fujisawa Y
Pathol Res Pract; 1995 Feb; 191(1):64-9; discussion 70-5. PubMed ID: 7651935
[TBL] [Abstract][Full Text] [Related]
20. Diazoxide prevents reactive oxygen species and mitochondrial damage, leading to anti-hypertrophic effects.
Lucas AM; Caldas FR; da Silva AP; Ventura MM; Leite IM; Filgueiras AB; Silva CG; Kowaltowski AJ; Facundo HT
Chem Biol Interact; 2017 Jan; 261():50-55. PubMed ID: 27867086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
